Human cytokine-induced killer cells specifically infiltrated and retarded the growth of the inoculated human cholangiocarcinoma cells in SCID mice

Cancer Investigation

Volumn 27, Issue 2, 2009, Pages 140-148

  Wongkajornsilp, Adisak ^a   Somchitprasert, Theera ^a   Butraporn, Raywadee ^c   Wamanuttajinda, Valla ^a   Kasetsinsombat, Kanda ^a   Huabprasert, Sukit ^a   Maneechotesuwan, Kittipong ^a   Hongeng, Suradej ^a,b,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Animal experiment; Cholangiocarcinoma; Cytokine induced killer cells

Indexed keywords

RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BILE DUCT CARCINOMA; CANCER INHIBITION; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL POPULATION; CELL THERAPY; COCULTURE; CONTROLLED STUDY; CYTOKINE INDUCED KILLER CELL; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KILLER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SAFETY; SCID MOUSE; T LYMPHOCYTE; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME; UPREGULATION;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD56; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; CYTOKINE-INDUCED KILLER CELLS; DENDRITIC CELLS; HUMANS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS;

EID: 60849138424     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802189832     Document Type: Article

References (23)

1. Watanapa, P.; Watanapa, W.B. Liver fluke-associated cholangiocarcinoma. Br J Surg 2002, 89 (8), 962-970.
2. Jarnagin, W.R.; Shoup, M. Surgical management of cholangiocarcinoma. Semin Liver Dis 2004, 24 (2), 189-199.
3. Wongkajornsilp, A.; Sangsuriyong, S.; Hongeng, S.; Waikakul, S.; Asavamongkolkul, A.; Huabprasert, S. Effective osteosarcoma cytolysis using cytokine-induced killer cells pre-inoculated with tumor RNA-pulsed dendritic cells. J Ortho Res 2005, 23 (6), 1460-1466.
4. Schmidt-Wolf, I.G.; Lefterova, P.; Mehta, B.A.; Fernandez, L.P.; Huhn, D.; Blume, K.G.; Weissman, I.L.; Negrin, R.S. Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol 1993, 21 (13), 1673-1679.
5. Mehta, B.A.; Schmidt-Wolf, I.G.; Weissman, I.L.; Negrin, R.S. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3+ CD56+ killer cells. Blood 1995, 86 (9), 3493-3499.
6. Linn, Y.C.; Hui, K.M. Cytokine-induced killer cells: NK-like T cells with cytotolytic specificity against leukemia. Leuk Lymphoma 2003, 44 (9), 1457-1462.
7. Marten, A.; Renoth, S.; von Lilienfeld-Toal, M.; Buttgereit, P.; Schakowski, F.; Glasmacher, A.; Sauerbruch, T.; Schmidt-Wolf, I. G. Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells. Haematologica 2001, 86 (10), 1029-1037.
8. Gonzalez-Carmona, M.A.; Marten, A.; Hoffmann, P.; Schneider, C.; Sievers, E.; Schmidt-Wolf, I.G.; Sauerbruch, T.; Caselmann, W. H. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells. Liver Int 2006, 26 (3), 369-379.
9. Shi, M.; Zhang, B.; Tang, Z.R.; Lei, Z.Y.; Wang, H.F.; Feng, Y.Y.; Fan, Z.P.; Xu, D.P.; Wang, F.S. Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinoma. World J Gastroenterol 2004, 10 (8), 1146-1151.
10. Parajuli, P.; Mathupala, S.; Sloan, A.E. Systematic comparison of dendritic cell-based immunotherapeutic strategies for malignant gliomas:In vitro induction of cytolytic and natural killer-like T cells. Neurosurgery 2004, 55 (5), 1194-1204.
11. Vichchatorn, P.; Wongkajornsilp, A.; Petvises, S.; Tangpradabkul, S.; Pakakasama, S.; Hongeng, S. Dendritic cells pulsed with total tumor RNA for activation NK-like T cells against glioblastoma multiforme. J Neurooncol 2005, 75 (2), 111-118.
12. Ziske, C.; Marten, A.; Schottker, B.; Buttgereit, P.; Schakowski, F.; Gorschluter, M.; von Rucker, A.; Scheffold, C.; Chao, N.; Sauerbruch, T.; Schmidt-Wolf, I.G. Resistance of pancreatic carcinoma cells is reversed by coculturing NK-like T cells with dendritic cells pulsed with tumor-derived RNA and CA 19-9. Mol Ther 2001, 3 (1), 54-60.
13. Schmidt, J.; Eisold, S.; Buchler, M.W.; Marten, A. Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma. Cancer Immunol Immunother 2004, 53 (11), 1018-1026.
14. Sievers, E.; Albers, P.; Schmidt-Wolf, I.G.; Marten, A. Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma. J Urol 2004, 171 (1), 114-119.
15. Erhardt, M.; Schmidt-Wolf, I.G.; Sievers, E.; Frank, S.; Strehl, J.; von Lilienfeld-Toal, M.; Gorschluter, M. Anti-tumoral capabilities of effector cells after IFN-alpha or CpG-motif treatment of cocultured dendritic cells. Arch Immunol Ther Exp (Warsz) 2006, 54 (6), 403-409.
16. Zhang, S.; Wang, Q.; Li, W.F.; Wang, H.Y.; Zhang, H.J. Enhanced antitumor immunity by murine cytokine activated T lymphocytes after cocultured with bone marrow derived dendritic cells pulsed with whole tumor lysates. Leuk Res 2004, 28 (10), 1085-1088.
17. Jiang, J.; Xu, N.; Wu, C.; Deng, H.; Lu, M.; Li, M.; Xu, B.; Wu, J.; Wang, R.; Xu, J.; Nilsson-Ehle, P. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. Anticancer Res 2006, 26 (3B), 2237-2242.
18. Leemhuis, T.; Wells, S.; Scheffold, C.; Edinger, M.; Negrin, R.S. A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma. Biol Blood Marrow Transplant 2005, 11 (3), 181-187.
19. Neri, S.; Mariani, E.; Meneghetti, A.; Cattini, L.; Facchini, A. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin Diagn Lab Immunol 2001, 8 (6), 1131-1135.
20. Wang, H.Y.; Wang, R.F. Regulatory T cells and cancer. Curr Opin Immunol 2007, 19 (2), 217-223.
21. Mahnke, K.; Ring, S.; Johnson, T.S.; Schallenberg, S.; Schonfeld, K.; Storn, V.; Bedke, T.; Enk, A.H. Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation. Eur J Immunol 2007, 37 (8), 2117-2126.
22. Li, H.; Yu, J.P.; Cao, S.; Wei, F.; Zhang, P.; An, X.M.; Huang, Z.T.; Ren, X.B. CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients. J Clin Immunol 2007, 27 (3), 317-326.
23. Introna, M.; Borleri, G.; Conti, E.; Franceschetti, M.; Barbui, A.M.; Broady, R.; Dander, E.; Gaipa, G.; D'Amico, G.; Biagi, E.; Parma, M.; Pogliani, E.M.; Spinelli, O.; Baronciani, D.; Grassi, A.; Golay, J.; Barbui, T.; Biondi, A.; Rambaldi, A. Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study. Haematologica 2007, 92 (7), 952-959.